日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol

多替拉韦治疗失败队列:一项多国纵向队列研究,在撒哈拉以南非洲地区开展了一项随机临床试验,比较在接受多替拉韦治疗期间出现病毒血症的患者中继续使用多替拉韦与改用达芦那韦的疗效(Ndovu 研究)方案

Ombajo, Loice Achieng; Nkuranga, Joseph; Penner, Jeremy; Kamau, Emily Wangui; Ismael, Nalia; Munseri, Patricia; Ayakaka, Irene; Labhardt, Niklaus; Wamalwa, Dalton; Ramgi, Patricia; Chissumba, Raquel Matavele; Wagude, James; Bakari, Muhammad; Omodi, Victor; Otieno, Edwin; Abuogi, Lisa; Patel, Rena; Opondo, Charles; Grint, Daniel; King'wara, Leonard; Macharia, AnneMarie; Mulwa, Andrew; Amoth, Patrick

Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine

莫桑比克人群接种1剂或2剂BBIBP-CorV疫苗后产生的混合免疫

Chissumba, Raquel Matavele; Kwatra, Gaurav; Ramgi, Patrícia; Enosse, Maria; Sigaúque, Adérito; Khosa, Celso; Viegas, Edna; Bule, Odete; Langa, José; Dhar, Nisha; Mukendi, Christian; Langa, Denise; Sevene, Esperança; Hermanus, Tandile; Manamela, Nelia; Richardson, Simone; Moore, Penny; Madhi, Shabir; Jani, Ilesh V

Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique

使用BBIBP-CorV和Ad26.COV2.S COVID-19疫苗的异源与同源初免-加强免疫方案的免疫原性和安全性:一项在马达加斯加和莫桑比克开展的多中心、随机、观察者盲法非劣效性试验

Ramgi, Patrícia; Siribie, Mohamadou; Rakotozandrindrainy, Njariharinjakamampionona; Bule, Odete; Shrivastava, Harshvardhan; Chambule, Lígia; Park, Eun Lyeong; Fernando, Carina; Boque, Jéssica; Macuiana, Rezelda; Razafimanantsoa, Ravomialisoa; Rakotozandrindrainy, Ndrainaharimira; Razafindrabe, Tsiriniaina J L; Rakotoarisoa, Antenaina N; Raminosoa, Tiana M; Derandrainy, Herinirina L; Rakotoson, Masinirina M; de Silva, Cynthia S S; Mutombene, Mirna; Massinga, Carmélia; Langa, José P; Guarnacci, Tobin; Kang, Sophie S Y; Jo, Sue Kyoung; Jeon, Hyon Jin; Excler, Jean-Louis; Yang, Yunkai; Wang, Shiyu; Sugimoto, Jonathan D; Yang, Jae Seung; Shim, Byoung-Shik; Binger, Tabea; Capitine, Igor U; Aziz, Asma B; Park, Ju Yeon; Kim, Deok Ryun; Rakotozandrindrainy, Raphaël; Jani, Ilesh V; Tadesse, Birkneh Tilahun; Marks, Florian

Why did I participate in an HIV vaccine study? Experiences of participation in the first phase II HIV vaccine trial in Mozambique: An ancillary study using a mixed-method approach

我为什么会参与艾滋病疫苗研究?参与莫桑比克首个二期艾滋病疫苗试验的经历:一项采用混合方法进行的辅助研究

Ubisse Capitine, Igor P; Manhiça, Álvaro Marcela; Tembe Júnior, Paulo; Ramgi, Patrícia M; Chicumbe, Sérgio; Kroidl, Arne; Fischer, Martin R; De Schacht, Caroline